Inokuchi Junichi

写真a

Title

Professor
To the head of this page.▲

Current Affiliation Organization 【 display / non-display 】

  • Duty   University of the Ryukyus   Graduate School of Medicine   Professor  

To the head of this page.▲

Published Papers 【 display / non-display 】

  • A Case of Spermatocytic Tumor of Testis.

    Nagamine S, Nakanishi Y, Tanaka K, Ashikari A, Kimura R, Nakanishi S, Kawamitsu R, Wada N, Nishie A, Inokuchi J

    IJU case reports ( Iju Case Reports )  8 ( 6 ) 563 - 566   2025.11 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

  • Efficacy of cisplatin-based neoadjuvant chemotherapy and risk factors for residual extravesical disease in muscle-invasive bladder cancer: insights from a nationwide cohort

    Saito, R; Taoka, R; Miki, J; Fukuokaya, W; Matsui, Y; Hatakeyama, S; Kawahara, T; Matsuda, A; Kawai, T; Sazuka, T; Kato, M; Sano, T; Urabe, F; Kashima, S; Naito, H; Murakami, Y; Miyake, M; Daizumoto, K; Matsushita, Y; Hayashi, T; Inokuchi, J; Sugino, Y; Shiga, K; Yamaguchi, N; Yamamoto, S; Yasue, K; Abe, T; Nakanishi, S; Hashine, K; Fujii, M; Nishihara, K; Matsumoto, H; Tatarano, S; Wada, K; Sekito, S; Maruyama, R; Nishiyama, N; Nishiyama, H; Kitamura, H; Kinoshita, H; Japan Urological Oncology Gro

    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY     2025.07 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

  • Impact of lymph-node dissection during radical cystectomy for non-muscle-invasive bladder cancer: Japanese multicenter retrospective study

    Sazuka, T; Taoka, R; Miki, J; Saito, R; Fukuokaya, W; Matsui, Y; Hatakeyama, S; Kawahara, T; Matsuda, A; Kawai, T; Kato, M; Sano, T; Urabe, F; Kashima, S; Naito, H; Murakami, Y; Miyake, M; Daizumoto, K; Matsushita, Y; Hayashi, T; Inokuchi, J; Sugino, Y; Shiga, K; Yamaguchi, N; Yamamoto, S; Yasue, K; Abe, T; Nakanishi, S; Hashine, K; Sawada, A; Nishihara, K; Matsumoto, H; Tatarano, S; Wada, K; Sekito, S; Maruyama, R; Nishiyama, N; Nishiyama, H; Kitamura, H; Ichikawa, T

    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY ( International Journal of Clinical Oncology )  30 ( 7 ) 1417 - 1425   2025.07 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

    • Access this article
      DOI
    • Search related information
      PubMed

  • Current Evidences and Future Perspectives in the Management of Metastatic Non-Clear Cell Renal Cell Carcinoma.

    Nakanishi S, Inokuchi J

    International journal of urology : official journal of the Japanese Urological Association ( International Journal of Urology )    2025.06 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

  • Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy

    Hara, S; Fukuokaya, W; Miki, J; Taoka, R; Saito, R; Matsui, Y; Hatakeyama, S; Kawahara, T; Matsuda, A; Kawai, T; Kato, M; Sazuka, T; Sano, T; Urabe, F; Kashima, S; Naito, H; Murakami, Y; Miyake, M; Daizumoto, K; Matsushita, Y; Hayashi, T; Inokuchi, J; Sugino, Y; Shiga, K; Yamaguchi, N; Yamamoto, S; Yasue, K; Abe, T; Nakanishi, S; Hashine, K; Fujii, M; Nishihara, K; Matsumoto, H; Tatarano, S; Wada, K; Sekito, S; Maruyama, R; Nishiyama, N; Nishiyama, H; Kitamura, H; Kimura, T

    INTERNATIONAL JOURNAL OF UROLOGY ( International Journal of Urology )  32 ( 5 ) 544 - 552   2025.05 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

display all >>

To the head of this page.▲

Other Papers 【 display / non-display 】

display all >>

To the head of this page.▲

Grant-in-Aid for Scientific Research 【 display / non-display 】

  • Development and investigation of clinical utility of simple sensor device for novel urinary cancer biomarkers detection

    Grant-in-Aid for Scientific Research(C)

    Project Year: 2023.04  -  2026.03 

    Direct: 3,600,000 (YEN)  Overheads: 4,680,000 (YEN)  Total: 1,080,000 (YEN)

  • Smart nanomedicine-mediated functional switching of macrophage and treatment of chronic kidney disease (CKD)

    Grant-in-Aid for Scientific Research(B)

    Project Year: 2022.04  -  2025.03 

    Direct: 10,200,000 (YEN)  Overheads: 13,260,000 (YEN)  Total: 3,060,000 (YEN)

  • Treatment of chronic kidney disease (CKD) by a bioinspired nanomaterial modulating macrophage polarization

    Grant-in-Aid for Scientific Research(B)

    Project Year: 2022.04  -  2025.03 

    Direct: 10,200,000 (YEN)  Overheads: 13,260,000 (YEN)  Total: 3,060,000 (YEN)

  • Development of a novel diagnostic method for urothelial carcinoma targeting urinary activated protein kinase C-alpha

    Grant-in-Aid for Scientific Research(C)

    Project Year: 2019.04  -  2022.03 

    Investigator(s): Inokuchi Junichi 

    Direct: 3,400,000 (YEN)  Overheads: 4,420,000 (YEN)  Total: 1,020,000 (YEN)

    　View Summary

    Urinary activated protein kinase Cα (PKCα) showed high sensitivity and specificity for detecting urothelial carcinoma (UC), even in low grade UC which had been shown low sensitivity to date. This result indicates the usefulness of activated PKCα as a novel urinary biomarker for urothelial carcinoma. Furthermore, we developed an electronic biosensor device using an anti-phosphopeptide antibody as a cheaper and simpler examination.

  • Development of novel diagnostic procedure for detection of upper urinary tract urothelial cancer

    Grant-in-Aid for Scientific Research(C)

    Project Year: 2016.04  -  2019.03 

    Investigator(s): Inokuchi Junichi, Grollman Arthur P. 

    Direct: 3,600,000 (YEN)  Overheads: 4,680,000 (YEN)  Total: 1,080,000 (YEN)

    　View Summary

    We hypothesized that a fraction of upper urinary tract urothelial carcinoma (UTUC) cases in Japan might result from past intake of aristolochic acid (AA), a powerful nephrotoxin and human carcinogen, which cause UTUC. In contrast to the high incidence of AA-associated UTUC in Taiwan cohort, our study indicated that confirmed AA-exposure in Japanese UTUC patients were rare. We examined the efficacy of activated protein kinase X in urine sample to detect urothelial cancer. We found the high sensitivity and specificity of this assay, and suggested the activated protein kinase X as promising biomarker for detecting urothelial cancer.

display all >>

To the head of this page.▲